Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Wilson

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Social Science & Medicine (1982)|September 6, 2023
The total health gains and cost savings of eradicating cold housing in AustraliaShiva Raj Mishra, Tim Wilson, Hassan Andrabi, et al.
Tobacco Control|July 7, 2025
Modelling the potential impacts of limiting vaping product sales to pharmaciesDriss Ait Ouakrim, Tim Wilson, Samantha Howe, et al.
European Urology|December 25, 2016
Corrigendum to: "The Influence of Baseline Parameters on Changes in IPSS with Dutasteride, Tamsulosin, and Combination Therapy: Two-Year Data from the Combination of Avodart<sup>®</sup> and Tamsulosin (CombAT) Study" [Eur Urol Suppl 2008;7:171 (Abstract no. 403)]Claus G Roehrborn, Andrea Tubaro, Francesco Montorsi, et al.
BMC Public Health|September 7, 2021
The individual, place, and wellbeing - a network analysisEoin McElroy, Mathew Ashton, Anne Marie Bagnall, et al.
Blood|January 31, 2004
Mechanisms and implications of phosphoinositide 3-kinase delta in promoting neutrophil trafficking into inflamed tissueKamal D Puri, Teresa A Doggett, Jason Douangpanya, et al.
Tobacco Control|January 10, 2023
Tobacco endgame intervention impacts on health gains and Māori:non-Māori health inequity: a simulation study of the Aotearoa/New Zealand Tobacco Action PlanDriss Ait Ouakrim, Tim Wilson, Andrew Waa, et al.
Mabs|May 16, 2025
Hybrid IgE-IgG1 antibodies (IgEG): a new antibody class that combines IgE and IgG functionalityMelanie Grandits, Lais C G F Palhares, Olivia Macleod, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 11, 2025
An IgE antibody targeting HER2 identified by clonal selection restricts breast cancer growth via immune-stimulating activitiesLais C G F Palhares, Melanie Grandits, Katie Stoker, et al.
Scientific Reports|March 30, 2026
Elucidating the relationship between affinity and potency in the performance of therapeutic IgEFrancesca Marano, Callum McKenzie, James R Birtley, et al.
Scientific Reports|May 15, 2026
Publisher Correction: Elucidating the relationship between affinity and potency in the performance of therapeutic IgEFrancesca Marano, Callum McKenzie, James R Birtley, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Social Science & Medicine (1982)|September 6, 2023
The total health gains and cost savings of eradicating cold housing in AustraliaShiva Raj Mishra, Tim Wilson, Hassan Andrabi, et al.
Tobacco Control|July 7, 2025
Modelling the potential impacts of limiting vaping product sales to pharmaciesDriss Ait Ouakrim, Tim Wilson, Samantha Howe, et al.
European Urology|December 25, 2016
Corrigendum to: "The Influence of Baseline Parameters on Changes in IPSS with Dutasteride, Tamsulosin, and Combination Therapy: Two-Year Data from the Combination of Avodart<sup>®</sup> and Tamsulosin (CombAT) Study" [Eur Urol Suppl 2008;7:171 (Abstract no. 403)]Claus G Roehrborn, Andrea Tubaro, Francesco Montorsi, et al.
BMC Public Health|September 7, 2021
The individual, place, and wellbeing - a network analysisEoin McElroy, Mathew Ashton, Anne Marie Bagnall, et al.
Blood|January 31, 2004
Mechanisms and implications of phosphoinositide 3-kinase delta in promoting neutrophil trafficking into inflamed tissueKamal D Puri, Teresa A Doggett, Jason Douangpanya, et al.
Tobacco Control|January 10, 2023
Tobacco endgame intervention impacts on health gains and Māori:non-Māori health inequity: a simulation study of the Aotearoa/New Zealand Tobacco Action PlanDriss Ait Ouakrim, Tim Wilson, Andrew Waa, et al.
Mabs|May 16, 2025
Hybrid IgE-IgG1 antibodies (IgEG): a new antibody class that combines IgE and IgG functionalityMelanie Grandits, Lais C G F Palhares, Olivia Macleod, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 11, 2025
An IgE antibody targeting HER2 identified by clonal selection restricts breast cancer growth via immune-stimulating activitiesLais C G F Palhares, Melanie Grandits, Katie Stoker, et al.
Scientific Reports|March 30, 2026
Elucidating the relationship between affinity and potency in the performance of therapeutic IgEFrancesca Marano, Callum McKenzie, James R Birtley, et al.
Scientific Reports|May 15, 2026
Publisher Correction: Elucidating the relationship between affinity and potency in the performance of therapeutic IgEFrancesca Marano, Callum McKenzie, James R Birtley, et al.
Pageof 6